ECM
GHDX

Endurant Capital Management’s Genomic Health, Inc. GHDX Stock Holding History

Endurant Capital Management’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-27,200
Closed -$756K – 101
2015
Q2 		$756K Buy
+27,200
New +$767K 0.22% 72

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Endurant Capital Management's GHDX Position: Q3 2015 in Review

Endurant Capital Management sold out of Genomic Health, Inc. (GHDX) in Q3 2015, closing a stake of 27,200 shares — an estimated $756K sold.

Endurant Capital Management first reported a position in GHDX in Q2 2015 and held it in 1 quarter. The position peaked at $756K in Q2 2015. 117 funds tracked by Wall St. Rank hold GHDX as of Q3 2015.

  • Endurant Capital Management reported no remaining Genomic Health, Inc. position as of Q3 2015 after selling out during the quarter.
  • Endurant Capital Management sold 27,200 Genomic Health, Inc. shares in Q3 2015, an estimated $756K.
  • Endurant Capital Management first reported a position in Genomic Health, Inc. in Q2 2015 and held it in 1 quarter.
  • Endurant Capital Management's Genomic Health, Inc. position peaked at $756K in Q2 2015.
  • 117 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2015.

Based on Endurant Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.